Custom cell line development as a documentation project, not a cloning project

Running the project

1. Choose the host from the molecule, not from habit. Mammalian hosts give human like glycosylation and are the default for complex secreted proteins and antibodies. Microbial hosts give speed and cost for proteins that fold without those modifications. The wrong host is recoverable only by starting again, so the decision belongs before any construct is built.
2. Fix the selection and screening funnel in advance. Agree how many clones enter screening, on what criteria they are ranked, and how many go forward. Titre alone is a poor ranking: growth profile, product quality and behaviour at the intended scale matter as much, and a clone that wins on titre in a plate frequently loses in a bioreactor.
3. Demonstrate clonality in a way someone can check. A single cell origin has to be evidenced, not asserted. Imaging at deposition, a documented limiting dilution with statistics, or both, is what the record needs. This is the item most often missing when a line arrives from a partner and the most expensive to reconstruct.
4. Build the bank structure before you need it. One master bank, working banks drawn from it, and physical separation between storage locations. Decide the vial counts against the projected campaign schedule, and decide them once, because a bank that runs out forces a new bank and a new comparability exercise.
5. Test the bank to a written panel. Identity, viability, recovery, sterility, mycoplasma and adventitious agent testing as the product type demands, with the panel agreed before the vials are filled. Testing after the fact against a panel nobody wrote is how a bank becomes unusable.
6. Run stability to the limit of the intended process. Culture the line past the generation count any campaign would reach and show that expression and product quality hold. A line stable through ten passages and failing at forty is a line you will discover at the worst possible moment.

Mammalian cell line development and microbial cell line development are not the same project

A mammalian development programme spends its time on clone screening and stability because expression is distributed across a heterogeneous pool and only a minority of clones are both productive and durable. A microbial programme spends its time on expression conditions, solubility and downstream recovery, because the organism grows fast and the difficulty moves to the protein rather than the cell.

That difference changes the shape of the quotation. A mammalian proposal that does not describe the screening funnel, or a microbial proposal that does not describe the expression optimisation, is describing half the work.

The bank is the asset, not the clone

Once a project ends, what you own is a set of vials and a file. The clone in the incubator will be discarded. If the vials are not distributed across separate storage, monitored and documented, a single equipment failure removes the entire output of a multi month programme.

Split the master bank across at least two physically separate locations with independent power and alarms, and keep the certificate, the testing panel and the passage history with the inventory record rather than in someone's project folder.

What to insist on in a contract

Ownership of the line and of any intermediate constructs. Delivery of raw screening data rather than a summary. The full testing panel and its results. The passage history. Any licence obligations attached to the host or to an editing technology used along the way.

The last of those catches people out. Host lines and editing tools frequently carry commercial terms that follow the cell line into your own process, and the time to discover them is before the project starts.

genetic stability testing, and what a bank has to show

A production cell line is judged on whether it still is what it was: identity by short tandem repeat or sequence, copy number and integration site for a transfected construct, absence of rearrangement over the passages the process will use, and, for a viral vector producer, absence of replication competent virus. The study runs the line to the limit of in vitro age and compares the end of production cells with the bank, which is what a regulator asks for and what takes months rather than weeks.

humanized mice price, and what the number covers

A humanized mice price depends on the model and the engraftment: a humanised immune system model needs immunodeficient recipients, a human cell source and weeks of engraftment with monitoring, and the quote should say whether engraftment verification and failures are included. Cohort size rather than per animal cost is what a study budget turns on.

ipsc crispr work and what it needs

ipsc crispr work is editing in a cell that is both hard to transfect and quick to lose pluripotency, so the delivery method, the single cell cloning and the post edit characterisation are the whole of the difficulty. Karyotype, pluripotency and an off target assessment are the minimum a line has to show afterwards.

A pc12 cell line and a differentiating model

A pc12 cell line is a rat neural crest line that extends processes on nerve growth factor, which makes it a differentiation model rather than a neuron, and the degree of differentiation is a variable rather than a state. Passage number changes how well it responds, which is why the stock is banked early.

u-251 mg and the glioma lines beside it

u-251 mg is a glioma line whose identity has been confused in the literature with another line from the same laboratory, which is one of the clearest arguments for profiling a line on arrival rather than trusting a label. The lines from this tumour type differ in their pathway lesions and are used as a panel.

Common questions

How long does a mammalian cell line project take?

Realistically several months from construct to a banked, characterised line, with screening and stability consuming most of it. Compressed timelines usually compress the stability work, which is the part that protects you later.

What makes a cell bank a GMP cell bank?

Manufacture under a quality system, with controlled materials, documented procedures, defined release testing and retained records, rather than any property of the cells. The same clone can be banked at research grade and at GMP grade, and the difference is entirely in the documentation and the environment.

Why is clonality evidence so important?

Because a heterogeneous population drifts, and a drifting population invalidates everything measured against it. Regulators and partners ask how single cell origin was demonstrated, and an answer of limiting dilution alone is increasingly treated as insufficient without supporting evidence.

Does an edited line need different banking?

It needs the same banking plus evidence about the edit: on target confirmation, characterisation of the insertion or disruption, and an assessment of off target effects proportionate to the use. The banking structure itself does not change.

Browse by service class

• Compare Gene synthesis on advertised prices